- Home
- FTLF vs ELDN Comparison
FTLF vs ELDN Comparison
Compare FTLF & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTLF | ELDN |
|---|---|---|
| Founded | 2005 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.6M | 166.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FTLF | ELDN |
|---|---|---|
| Price | $15.01 | $2.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $23.00 | $8.50 |
| AVG Volume (30 Days) | 13.5K | ★ 548.9K |
| Earning Date | 03-26-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.68 | N/A |
| Revenue | ★ $70,561,000.00 | N/A |
| Revenue This Year | $32.74 | N/A |
| Revenue Next Year | $50.36 | N/A |
| P/E Ratio | $20.93 | ★ N/A |
| Revenue Growth | ★ 12.44 | N/A |
| 52 Week Low | $9.83 | $1.35 |
| 52 Week High | $20.98 | $4.65 |
Technical Indicators
Market Signals| Indicator | FTLF | ELDN |
|---|---|---|
| Relative Strength Index (RSI) | 42.13 | 54.75 |
| Support Level | $13.42 | $1.96 |
| Resistance Level | $16.00 | $2.22 |
| Average True Range (ATR) | 0.65 | 0.15 |
| MACD | -0.10 | -0.02 |
| Stochastic Oscillator | 46.43 | 46.67 |
Price Performance
Historical ComparisonAbout FTLF FitLife Brands Inc.
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori, and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.